deltatrials
Active Not Recruiting OBSERVATIONAL NCT00587886

Estrogen, Diet, Genetics and Endometrial Cancer

Sponsor: Department of Health and Human Services

Interventions Questionnaire
Updated 21 times since 2017 Last updated: Apr 10, 2025 Started: Sep 25, 2001 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cancer and Corpus Uteri and is currently ongoing. Department of Health and Human Services leads this study, which shows 21 recorded versions since 2001 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Study Description(click to expand)

We will conduct a population-based case-control study in six counties of New Jersey. Cases will be women with newly-diagnosed endometrial or ovarian cancer. Controls will be matched by 5-year age groups and selected by random digit dialing (for those under 65), from Centers for Medicare and Medicaid Services (CMS) files (for those 65 and over), or from neighborhood sampling. Controls will not have had a hysterectomy. There will be 400 cases with endometrioid tumors, 60 with serous tumors or clear cell tumors, 300 with ovarian cancer, and 400 controls. In addition, there will be a small group of black women included from MSKCC. We will interview participants about known and potential risk factors for endometrial and ovarian cancer and obtain information on diet. We will obtain DNA for genetic analysis from buccal specimens collected using a mouthwash rinse method. We will use logistic regression to determine odds ratios for disease with various exposures. For endometrial cancer, we will examine the association of risk with genotypes in strata defined by body mass index and dietary fat consumption.

We will conduct a population-based case-control study in six counties of New Jersey. Cases will be women with newly-diagnosed endometrial or ovarian cancer. Controls will be matched by 5-year age groups and selected by random digit dialing (for those under 65), from Centers for Medicare and Medicaid Services (CMS) files (for those 65 and over), or from neighborhood sampling. Controls will not have had a hysterectomy.

There will be 400 cases with endometrioid tumors, 60 with serous tumors or clear cell tumors, 300 with ovarian cancer, and 400 controls. In addition, there will be a small group of black women included from MSKCC.

We will interview participants about known and potential risk factors for endometrial and ovarian cancer and obtain information on diet. We will obtain DNA for genetic analysis from buccal specimens collected using a mouthwash rinse method. We will use logistic regression to determine odds ratios for disease with various exposures. For endometrial cancer, we will examine the association of risk with genotypes in strata defined by body mass index and dietary fat consumption.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Feb 2020 · 12 months · monthly snapshot~Feb 2020 – ~Nov 2020 · 9 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Dec 2021 · 10 months · monthly snapshot~Dec 2021 – ~Feb 2022 · 2 months · monthly snapshot~Feb 2022 – ~Feb 2023 · 12 months · monthly snapshot~Feb 2023 – ~Feb 2024 · 12 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~May 2025 · 3 months · monthly snapshot~May 2025 – present · 11 months · monthly snapshot~Jan 2026 – present · 3 months · monthly snapshot

Change History

21 versions recorded
  1. Jan 2026 — Present [monthly]

    Active Not Recruiting

  2. May 2025 — Present [monthly]

    Active Not Recruiting

  3. Feb 2025 — May 2025 [monthly]

    Active Not Recruiting

  4. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

Show 16 earlier versions
  1. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting

  2. Feb 2023 — Feb 2024 [monthly]

    Active Not Recruiting

  3. Feb 2022 — Feb 2023 [monthly]

    Active Not Recruiting

  4. Dec 2021 — Feb 2022 [monthly]

    Active Not Recruiting

  5. Feb 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  6. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting

  7. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  8. Feb 2020 — Nov 2020 [monthly]

    Active Not Recruiting

  9. Feb 2019 — Feb 2020 [monthly]

    Active Not Recruiting

  10. Jan 2019 — Feb 2019 [monthly]

    Active Not Recruiting

  11. Jun 2018 — Jan 2019 [monthly]

    Active Not Recruiting

  12. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting

  13. Apr 2018 — May 2018 [monthly]

    Active Not Recruiting

    Phase: NANone

  14. Aug 2017 — Apr 2018 [monthly]

    Active Not Recruiting NA

  15. Feb 2017 — Aug 2017 [monthly]

    Active Not Recruiting NA

  16. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Sep 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Department of Health and Human Services
  • Memorial Sloan Kettering Cancer Center
  • Municipal Institute of Medical Research
  • National Cancer Institute (NCI)
  • Penn State University
  • Rutgers Cancer Institute of New Jersey
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations